Figure 5 | British Journal of Cancer

Figure 5

From: MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker

Figure 5

Expression of Ecm29 in clinical PCa specimens. (A) Ecm29 mRNA expression levels were determined by qRT–PCR analysis in PCa, non-PCa, and CRPC specimens. GUSB was used as an internal control. (B) Ecm29 expression in CRPC specimens. High expression of Ecm29 was found in the cytoplasm of CRPC cells, whereas the expression was low in the nucleus. (C) Inverse correlation between Ecm29 mRNA and miR-221 expression. (D) Inverse correlation between Ecm29 mRNA and miR-222 expression.

Back to article page